Skin and soft-tissue abscesses, a common problem among injection drug users (IDUs), result in serious morbidity for the patient and costly hospitalizations for incision and drainage; however, there has been little etiologic or preventive epidemiologic research on this problem. We performed a case-control study that enrolled 151 IDUs who had been given a new diagnosis of abscess requiring incision and drainage (cases) and 267 IDUs who did not have abscess or other bacterial infection during the previous year and who were stratummatched to cases according to age, sex, and race (controls). Subcutaneous or intramuscular, instead of intravenous, injection is a major risk factor for abscess among IDUs. The injection of a cocaine and heroin mixture, or "speedball," may predispose patients to develop abscess by inducing soft-tissue ischemia. Cleaning the skin with alcohol before injection was found to have a protective effect. Neither human immunodeficiency virus nor human T-lymphotropic virus type II seropositivity was significantly associated with abscess.
or public insurance coverage [4] . Previous studies have indicated that skin and mouth flora, including Staphylococcus aureus, facultative gram-negative bacteria, and mixed anaerobic bacteria, are the most common microbiologic pathogens [5, 6] . One study also found that a failure to clean the skin before injection of drugs was associated with a diagnosis of abscess [7] .
However, the incidence of abscess, the risk factors associated with its occurrence, and the best treatment and preventive measures have been the focus of little recent investigation [8] . Clinical and anthropologic data support high rates of incidence and recurrence of abscess among largely homeless and destitute IDUs [9, 10] ; however, good epidemiologic data on the rates of incidence and recurrence of abscess among IDUs are not available. There is much anecdotal information that relates abscess to a lack of use of sterile procedures at the time of drug injection, and there is much speculation with regard to risk factors, such as the site of injection and the contamination of illegal drugs with bacteria and irritants. HIV and human T-lymphotropic virus type II (HTLV-II) may predispose patients to develop abscess, but this has not been confirmed [11] [12] [13] . In the absence of clinical trials, treatment for abscess has followed the timehonored and effective principles of surgical drainage of pus, debridement of necrotic tissue, and supplemental antibiotic therapy [14] . However, such treatment often requires time in the operating room and 2-3 days of inpatient hospitalization, rendering such care expensive [4] . Although prevention of injection drug use-related viral infections has received recent attention [15] , to our knowledge no clinical trials of prevention strategies or new treatment protocols for injection drug use-associated abscess have been published.
Clinical research into injection drug use-related abscess is important because this infection causes significant morbidity among IDUs, as was illustrated by the recent outbreak of fatal soft-tissue infections among IDUs in Scotland, Ireland, and England [16] , and because financial pressures on inner-city hospitals have spurred a reexamination of treatment protocols and possible prevention interventions [17] . We therefore undertook a case-control study of the risk factors for abscess among IDUs who presented at an inner-city hospital. Our primary hypothesis was that HTLV-II was associated with an increased occurrence of abscess, but we also examined HIV infection status and a number of drug injection behaviors as potential risk factors.
METHODS
Study design and population. We chose a case-control design for our study to avoid biases inherent in cross-sectional studies and the logistic difficulties associated with a prospective cohort study. Cases were IDUs who had injected drugs within the past 6 months and who had a new diagnosis of abscess for which they received treatment in the inpatient wards or emergency room of San Francisco General Hospital, San Francisco. Controls were IDUs who had injected drugs within the past 6 months and who had no history of abscess or other major bacterial infection within the past year. Controls were recruited from among inpatients and outpatients at the same hospital and from a community-based epidemiologic study of injection drug use in the catchment area of the hospital. Controls were recruited simultaneously for this study and for a companion case-control study of bacterial pneumonia, leading to a control: case ratio of ∼2:1 in this analysis. Controls were stratummatched to cases with abscess or pneumonia, according to age (age groups, !30 years, 30-39 years, 40-49 years, and 150 years), sex, and race (white, black, and Hispanic/other). All subjects were 18 years of age or older, spoke English, and were able to give written informed consent.
After consent was obtained, the subjects' medical records were reviewed to confirm eligibility and to obtain information on other relevant diagnoses. Subjects were then interviewed by the study nurse to obtain information on medical history, drug injection practices, history of cigarette smoking and alcohol use, socioeconomic status, and other potential risk factors and confounding variables. Blood was obtained for HTLV-II and HIV serologic testing, and the results of such testing, in addition to appropriate counseling and referral, were communicated to the subjects during a return appointment.
Laboratory testing. Serum samples were first tested for antibody to HIV by use of an EIA (Vironostika HIV-1; Organon Teknika) and for antibody to human T-lymphotropic virus type I (HTLV-I) and HTLV-II by use of a well-characterized immunofluorescence assay (California State Department of Health Services, Berkeley). Samples for which the results of these screening assays were positive were retested by use of the more specific Western blot assay for HIV (HIV-1 Western blot [CBC]; Ortho Clinical Diagnostics) or for HTLV-I and HTLV-II (Genelabs Diagnostics HTLV Blot 2.4; Cellular Products). The HTLV Western blot assay allowed for discrimination of antibody to HTLV-I and HTLV-II. Two controls who were HTLV-I seropositive were eliminated from the analysis, and 14 samples (from 6 controls and 8 cases) that had indeterminate results on HTLV Western blot analysis were retained in our analysis as being negative for HTLV because previous research has demonstrated that such samples are rarely infected with HTLV-I or HTLV-II [18] . Rare samples that had discordant results on screening tests and Western blot analysis, or that had unusual patterns of Western blot reactivity, were resolved by use of PCR with primers directed at HTLV-I and HTLV-II pol gene sequences, as described elsewhere [19] .
Statistical analysis. In preliminary analysis, unadjusted associations with case status versus control status were assessed by use of tests. Independent predictors of abscess were then 2 x identified using multivariate logistic regression. Variables that were associated with abscess at a significance of in the P ! .1 preliminary analysis were considered for inclusion in the final multivariate model, which controlled for the frequency-matching variables (sex, age, and race or ethnicity). Inclusion of other covariates in the final model took into account statistical significance, biological plausibility, and goodness of fit. Interaction between drawing blood into the syringe before injection of drugs, known as "booting," and sc or im injection of drugs, known as "skin-popping," was examined because of the complex pattern of unadjusted and adjusted associations that involve these 2 predictors. Because the skin-popping variable was not ascertained for many controls, the expected frequency of skin-popping was also imputed for these participants by use of a multivariable linear model. Predictors in the model included age, race or ethnicity, and frequency of booting and cooking injection drugs. The parameters used for imputation were estimated with the use of data for cases and controls for whom data on these variables were not missing.
RESULTS
The demographic and other characteristics of the study population are described in table 1. Cases and controls were of similar age and race and had equivalent educational achievement and income. Controls were more likely than were cases to be men ( ) because they were matched with predom-P ! .001 inantly male cases with pneumonia in a companion study. There was a high prevalence of current alcohol intake and cigarette smoking among both cases and controls.
Univariate comparisons of cases and controls, with regard to various potential risk factors for abscess, are shown in table 2. Our primary hypothesis of an association between HTLV-II seropositivity and abscess was rejected, with 26% of cases and 25% of controls having HTLV-II antibody ( ). HIV sero-P p .74 prevalence was also similar among cases (12%) and controls (16%;
). Although heroin was the drug that had been P p .14 injected by the highest proportion of subjects, most of the study population had injected multiple drugs. Only the lifetime prevalence of injection of a heroin and cocaine mixture, known as a "speedball," was significantly higher among cases (88%), compared with controls (73%;
). Cases were also signifi-P ! .001 cantly more likely to have a higher lifetime frequency of speedball injection ( , by Mantel-Haenszel test). Skin-2 P p .001 x popping was significantly more common among cases (86%) than among controls (36%; P ! .001). Because the questionnaires that were given to controls early in the study did not ask about skin-popping, imputation of missing responses increased the prevalence of skin-popping among controls to 49% (133 of 272 controls), but the significant difference between cases and controls persisted (
). Use of a needle after P ! .001 someone else had used it and use of a dirty needle were both significantly more common among cases than among controls. Booting was less common among cases than among controls. However, booting was significantly less common among subjects who skin-popped compared with those who did not ( ), a finding that indicates possible confounding by P p .001 the latter variable. Significantly fewer cases, in comparison with controls, had ever used alcohol to clean their skin before drug injection (
). Finally, a history of severe acne was unusual P ! .001 among all subjects but was significantly more common among cases than among controls ( ). P p .02 To adjust for minor demographic differences between cases and controls and to eliminate confounding, a multivariable model was constructed (table 3) . The model contained a significant inverse association with male sex, but this association may not be interpreted because controls were matched as a group for this variable. Significant risk factors for abscess included skin-popping, use of a dirty needle, and speedball injection. Despite its apparent inverse association with abscess in the univariate analysis, booting was positively associated with abscess in the multivariable analysis and showed an interaction with skin-popping status. Among subjects who did not skinpop, booting was associated with an OR of 2.33 for abscess, whereas among those who did skin-pop, booting was associated with an OR of only 1.56. The only variable that was found to be significantly protective against abscess was cleaning the skin with alcohol before injection. Because a history of severe acne was no longer significant after we adjusted for other variables, it was dropped from the logistic model. Because the main model included only 192 controls, mainly as a result of missing responses to the question about skinpopping on the questionnaire, a second model was constructed that included imputed responses for this question. ORs derived from the second model (not shown) were comparable to those 
DISCUSSION
This study has demonstrated that several potentially modifiable risk factors are associated with an increased risk of skin and soft-tissue abscess among IDUs. Skin-popping was the strongest risk factor for abscess, followed by use of dirty needles and injection of a speedball. Booting was a stronger risk factor among those who did not perform skin-popping. Finally, cleaning the skin with alcohol before injection of drugs was the only independent protective factor among the predictor variables that were analyzed. Male sex was inversely associated with abscess and may be truly associated with a lower risk of abscess, as was reported for male sex elsewhere [11] . However, we cannot comment on this association because controls were selected in strata on the basis of this variable. The formation of an injection drug use-related skin or softtissue abscess probably represents the culmination of several discrete pathologic processes [20] . Analogous to sterile abscesses that result from the injection of caustic or irritating medications, there may be local injury or necrosis caused by the mass effect and chemical properties of the injected substance. The resolution of sterile abscess depends on local inflammation, which is in turn mediated by adequate circulation of blood and lymphatic fluid to the involved tissues and an intact immune response. Finally, a small bacterial inoculum injected into the soft-tissues may be contained and resolved, given optimal conditions for local immune response. However, either a higher dose of bacteria or the concomitant injection of substances that predispose the patient to the development of sterile abscess may overcome these defenses and result in bacterial proliferation, pus production, and tissue damage. Several of the risk factors for abscess that we have identified may be interpreted in the context of this pathologic process.
First, skin-popping results in the introduction of irritative substances and, frequently, bacteria directly into tissues. Although iv injection carries other systemic risks, it avoids this local concentration of irritants and bacteria. Skin-popping has been described elsewhere as a clinical characteristic of patients with injection drug use-related abscesses of the hand [21] , as a risk factor for abscess in a recent cross-sectional epidemiologic study [22] , and in association with injection drug use-related tetanus, especially among IDUs who have been vaccinated against tetanus [23] . Skin-popping may also be implicated in the recent outbreak of fatal injection drug use-related infections among IDUs in Scotland, Ireland, and England [16] . Second, we identified the practice of booting as an independent risk factor for abscess, particularly among IDUs who did not skinpop. This may be caused by extravasation of the drug and blood mixture from the vein, which provides both a local mass effect and nutrient media for bacterial growth [20] . We were unable to find other analytic studies that reported booting as a risk factor for abscess.
The fact that the injection of a speedball was identified as a risk factor for abscess may be etiologically significant or merely an indicator of a particular subgroup of IDUs who are at risk for abscess because of other reasons. Injection of heroin or cocaine alone was not an independent risk factor. However, it is conceivable that the mixture of the 2 drugs produces both local irritation and tissue vasoconstriction that act synergistically to increase the risk of infection, as has been suggested elsewhere [11, 24] . There have been anecdotal reports that bacterial contamination of recently available "black tar" heroin in California is linked to abscesses [25] and, perhaps, to wound botulism [26, 27] . We did not find evidence of an independent effect of injection of unmixed heroin, but we could have missed a recent association with black tar heroin, because we asked for a lifetime history of drug preference rather than a recent history of drug preference and because we did not differentiate black tar heroin from other types of heroin.
The use of dirty needles and the lack of skin cleaning with alcohol are 2 potentially preventable risk factors for abscess that were identified by this study. Hygiene clearly is important in abrogating the introduction of bacteria through the skin. The predominant flora identified in injection drug use-related abscess have been consistently reported to be S. aureus, facultative gram-negative bacteria, and anaerobic bacteria [6] . That septic abscess is a rare complication of medically administered sc and im injections attests to the importance of simple precautions, such as the use of clean needles and syringes and skin asepsis, in the prevention of infection. Although extensive efforts have not been made to teach drug users to avoid bacterial contamination when they inject drugs, our data suggest that such efforts may be warranted to reduce the considerable burden of disease caused by abscesses in this population. If the serious disease consequences are explained to IDUs, interventions aimed at changing their injection behavior may be successful, as has been shown for needle exchange and HIV prevention measures [15, 28, 29] . In addition, because medical treatment for opiate addiction is effective [30] but not available to all IDUs [31] , expanding access to methadone maintenance programs is another intervention that may reduce the incidence of soft-tissue infections [32] .
Although HTLV-II infection has been associated with an increased risk of bacterial infection [13, 33] , the current data did not support our initial hypothesis that HTLV-II infection was associated with an increased risk of abscess. Nor did we find a significant association with HIV infection. Although not statistically significant, our adjusted OR of 1.54 for HIV infection was nearly identical to the statistically significant adjusted rate ratio of 1.55 that was reported in a previously published prospective cohort study [11] . Our study could have missed a small HIV effect because of lower statistical power. Nevertheless, the small magnitude of the measured associations suggests that cellular or humoral immune functions that are affected by HIV infection are less important in preventing abscess than in preventing other systemic infections. Previous studies that indicated that HTLV-II was associated with abscess [12] , including our study of a similar patient population [13] , may have been confounded by factors related to both abscess and HTLV-II seropositivity, such as sex, race, and frequency of drug injection.
The strengths of this study include (1) use of a case-control, rather than a cross-sectional, design; (2) matching for potential demographic confounders; and (3) selection of well-characterized cases and both hospital and community controls. The weaknesses of this study include missing data on the skinpopping variable for some subjects and small imbalances in the matching of controls that were caused by the use of the same group of controls for the comparison study of injection drug use-related pneumonia. Finally, all retrospective studies are limited by the difficulty of obtaining accurate information on past drug injection practices and drug preferences by interview. Despite these weaknesses, the risk factors that were significant in the multivariable model are consistent with those found by other studies and are biologically plausible, supporting a causal relationship to abscess.
In conclusion, we have identified several plausible risk factors for injection drug use-related abscess, including skin-popping, speedball injection, use of dirty needles, and lack of adequate skin cleaning. Because at least one previous prospective cohort study has reported similar findings, we believe that these risk factors are etiologically related to abscess among active IDUs. Therefore, we recommend that a clinical trial of an intervention that consists of education about abscess risk factors combined with provision of clean needles and alcohol swabs be performed in this population. Such a trial would be important because it would indicate whether the expense and difficulty of such a program would be worth the measured benefit. In the meantime, public health authorities may favor the immediate institution of such preventive measures as an interim measure.
